Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study

Pulmonary Pharmacology and Therapeutics

Volumn 37, Issue , 2016, Pages 89-94

  Serafino Agrusa, Laura ^a   Scichilone, Nicola ^a   Spatafora, Mario ^a   Battaglia, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Biological markers blood; COPD; Eosinophils; Glucocorticoids administration dosage; Length of stay

Indexed keywords

CORTICOSTEROID;

AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EOSINOPHIL; EOSINOPHILIA; FEMALE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EOSINOPHILIA; EOSINOPHILS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84962507805     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2016.03.004     Document Type: Article

References (32)

1. Global Strategy for the Diagnosis Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014, Available from:. http://www.goldcopd.org/.
2. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007, 176:532-555.
3. Halpin D. NICE guidance for COPD. Thorax 2004, 59:181-182.
4. Bhowmik A., Seemungal T.A., Sapsford R.J., Wedzicha J.A. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000, 55:114-120.
5. Papi A., Bellettato C.M., Braccioni F., Romagnoli M., Casolari P., Caramori G., Fabbri L.M., Johnston S.L. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006, 173:1114-1121.
6. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., Maccallum P., Meade T.W., Jeffries D.J., Johnston S.L., Wedzicha J.A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001, 164:1618-1623.
7. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008, 359:2355-2365.
8. Bafadhel M., McCormick M., Saha S., McKenna S., Shelley M., Hargadon B., Mistry V., Reid C., Parker D., Dodson P., Jenkins M., Lloyd A., Rugman P., Newbold P., Brightling C.E. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration 2012, 83:36-44.
9. Saha S., Brightling C.E. Eosinophilic airway inflammation in COPD. Int. J. Chron. Obstruct Pulmon Dis. 2006, 1:39-47.
10. Saetta M., Di Stefano A., Maestrelli P., Turato G., Ruggieri M.P., Roggeri A., Calcagni P., Mapp C.E., Ciaccia A., Fabbri L.M. Airway eosinophilia in chronic bronchitis during exacerbations. Am. J. Respir. Crit. Care Med. 1994, 150:1646-1652.
11. Saetta M., Di Stefano A., Maestrelli P., Turato G., Mapp C.E., Pieno M., Zanguochi G., Del Prete G., Fabbri L.M. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin. Exp. Allergy 1996, 26:766-774.
12. Pizzichini E., Pizzichini M.M., Gibson P., Parameswaran K., Gleich G.J., Berman L., Dolovich J., Hargreave F.E. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am. J. Respir. Crit. Care Med. 1998, 158:1511-1517.
13. Brightling C.E., Monteiro W., Ward R., Parker D., Morgan M.D., Wardlaw A.J., Pavord I.D. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000, 356:1480-1485.
14. Brightling C.E., McKenna S., Hargadon B., Birring S., Green R., Siva R., Berry M., Parker D., Monteiro W., Pavord I.D., Bradding P. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005, 60:193-198.
15. Bafadhel M., Saha S., Siva R., McCormick M., Monteiro W., Rugman P., Dodson P., Pavord I.D., Newbold P., Brightling C.E. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration 2009, 78:256-262.
16. Siva R., Green R.H., Brightling C.E., Shelley M., Hargadon B., McKenna S., Monteiro W., Berry M., Parker D., Wardlaw A.J., Pavord I.D. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur. Respir. J. 2007, 29:906-913.
17. Bafadhel M., McKenna S., Terry S., Mistry V., Reid C., Haldar P., McCormick M., Haldar K., Kebadze T., Duvoix A., Lindblad K., Patel H., Rugman P., Dodson P., Jenkins M., Saunders M., Newbold P., Green R.H., Venge P., Lomas D.A., Barer M.R., Johnston S.L., Pavord I.D., Brightling C.E. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 2011, 184:662-671.
18. Anthonisen N.R., Manfreda J., Warren C.P., Hershfield E.S., Harding G.K., Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern Med. 1987, 106:196-204.
19. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987, 40:373-383.
20. Divo M., Cote C., de Torres J.P., Casanova C., Marin J.M., Pinto-Plata V., Zulueta J., Cabrera C., Zagaceta J., Hunninghake G., Celli B., Group B.C. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012, 186:155-161.
21. Ringbaek T.J., Lange P. Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD). Clin. Rehabil. 2005, 19:331-338.
22. Bafadhel M., McKenna S., Terry S., Mistry V., Pancholi M., Venge P., Lomas D.A., Barer M.R., Johnston S.L., Pavord I.D., Brightling C.E. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am. J. Respir. Crit. Care Med. 2012, 186:48-55.
23. O'Donnell D.E., Aaron S., Bourbeau J., Hernandez P., Marciniuk D.D., Balter M., Ford G., Gervais A., Goldstein R., Hodder R., Kaplan A., Keenan S., Lacasse Y., Maltais F., Road J., Rocker G., Sin D., Sinuff T., Voduc N. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can. Respir. J. 2007, 14(Suppl B):5B-32B.
24. Perera W.R., Hurst J.R., Wilkinson T.M., Sapsford R.J., Müllerova H., Donaldson G.C., Wedzicha J.A. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur. Respir. J. 2007, 29:527-534.
25. Fujimoto K., Yasuo M., Urushibata K., Hanaoka M., Koizumi T., Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur. Respir. J. 2005, 25:640-646.
26. Sayiner A., Aytemur Z.A., Cirit M., Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest 2001, 119:726-730.
27. Wood-Baker R., Walters J., Walters E.H. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews. Respir. Med. 2007, 101:371-377.
28. Walters J.A., Gibson P.G., Wood-Baker R., Hannay M., Walters E.H. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2009, CD001288.
29. Cheng T., Gong Y., Guo Y., Cheng Q., Zhou M., Shi G., Wan H. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials. Clin. Respir. J. 2013, 7:305-318.
30. Bafadhel M., Greening N.J., Harvey-Dunstan T.C., Williams J.E., Morgan M.D., Brightling C.E., Hussain S.F., Pavord I.D., Singh S.J., Steiner M.C. Blood eosinophils and outcomes in severe hospitalised exacerbations of COPD. Chest 2016, [Epub ahead of print], DOI: 10.1016/j.chest.2016.01.026.
31. Hasegawa K., Camargo C.A. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD. Respirology 2015, [Epub ahead of print], DOI: 10.1111/resp.12724.
32. Salturk C., Karakurt Z., Adiguzel N., Kargin F., Sari R., Celik M.E., Takir H.B., Tuncay E., Sogukpinar O., Ciftaslan N., Mocin O., Gungor G., Oztas S. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?. Int. J. Chron. Obstruct Pulmon Dis. 2015, 10:1837-1846.